High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy.

MLA

Shein, Aye Mya Sithu, et al. “High Prevalence of MgrB-Mediated Colistin Resistance among Carbapenem-Resistant Klebsiella Pneumoniae Is Associated with Biofilm Formation, and Can Be Overcome by Colistin-EDTA Combination Therapy.” Scientific Reports, vol. 12, no. 1, July 2022, p. 12939. EBSCOhost, https://doi.org/10.1038/s41598-022-17083-5.

APA

Shein, A. M. S., Wannigama, D. L., Higgins, P. G., Hurst, C., Abe, S., Hongsing, P., Chantaravisoot, N., Saethang, T., Luk-In, S., Liao, T., Nilgate, S., Rirerm, U., Kueakulpattana, N., Srisakul, S., Aryukarn, A., Laowansiri, M., Hao, L. Y., Yonpiam, M., Ragupathi, N. K. D., … Chatsuwan, T. (2022). High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy. Scientific Reports, 12(1), 12939. https://doi.org/10.1038/s41598-022-17083-5

Chicago

Shein, Aye Mya Sithu, Dhammika Leshan Wannigama, Paul G Higgins, Cameron Hurst, Shuichi Abe, Parichart Hongsing, Naphat Chantaravisoot, et al. 2022. “High Prevalence of MgrB-Mediated Colistin Resistance among Carbapenem-Resistant Klebsiella Pneumoniae Is Associated with Biofilm Formation, and Can Be Overcome by Colistin-EDTA Combination Therapy.” Scientific Reports 12 (1): 12939. doi:10.1038/s41598-022-17083-5.